Chengdu at the age of 13-14 in school-age girls inocus HPV vaccine-choose domestic vaccines to enjoy free policies!

Cervical cancer is one of the common tumors of gynecology in the world. According to research data, China's new cases of cervical cancer in 2020 ranks second in the world.

In 2020, the World Health Organization issued the "Accelerating the Elimination of Cervical Cancer Global Strategy", which proposed that by 2030, 90%of the people should complete the goal of HPV vaccination before the age of 15.

In November 2021, Chengdu officially launched the HPV vaccination work in school -age girls. As of now, more than 110,000 girls in schools have participated in vaccination.

This year, there are new good news! In September 2022, the Chengdu Municipal Health and Health Commission, the Municipal Education Bureau, and the Municipal Finance Bureau revised the "Implementation Plan for the Integrated HPV Vaccine Vaccination of Cervical Cervices" in Chengdu, in addition to the principle of "knowing consent, independent selection, voluntary vaccination" in accordance with the principle of "knowing consent, independent selection, voluntary vaccination" In addition to the subsidy standard of 600 yuan/person, Chengdu also incorporates the newly listed domestic second -price HPV vaccine "Wawzawi" this year into the project seedlings. The selection of this vaccine will achieve free vaccine and benefit more appropriate age at school. girl.

1 Why do you need to vaccinate the HPV vaccine?

Answers to cervical cancer are closely related to the continuous infection of human papilloma virus (HPV). In recent years, it has shown a trend of aging, becoming a "major killer" that affects women's health, and has a heavy burden on family and society. The vaccination of HPV vaccines can reduce the risk of vaccine -related diseases, and the effect is more obvious among women who have never been infected with HPV. Therefore, vaccination at a high risk of infection can minimize the chance of infection and dissemination.

2 Which groups of Chengdu's HPV vaccine Huimin project covers the HPV vaccine?

Answer a school-age girl at the age of 13-14 at that time, calculated at the age of 13 when the first agent HPV vaccine was vaccinated (the birth date of 2022 was born from January 1, 2008 to December 31, 2009) If there is no history of HPV vaccination, you can enjoy the city's HPV vaccine project for school -age girls in our city.

3 What are the HPV vaccines including Huimin project?

A: At present, there are 4 HPV vaccines suitable for the 13-14 age section in China, with a total of 4 product regulations, namely domestic binary (Woksawa, Xin Konin), imported two-valent (Herrai). Da Xiu) has been incorporated into the HPV vaccination project in Chengdu in Chengdu.

4 What are the differences between different HPV vaccines?

Answer the "price" of the HPV vaccine refers to the number of other viral types. At present, there are about 200 HPV types, which are divided into high -risk types and low -risk types. The most common high -risk types in China are mainly HPV16 and type 18. The two most common types. Therefore, effective prevention of HPV16 and type 18 infections are the focus of first -level prevention of cervical cancer. The two -valent HPV vaccine covers HPV16 and 18 types. No matter which HPV vaccine is selected, just inoculate.

5 How do girls in our school participate in the HPV vaccine inoculation of Huimin project?

Answer 2022 The registration of the HPV vaccination project in school -age girls in school has been carried out in various districts (cities) and counties. After the start of school, parents choose the vaccine variety and fill in the willingness of vaccination. The unit's vaccination clinic at the school is located.

Kind tips:

The younger the age and the earlier, the better the protection effect. Parents and friends are requested to understand in advance to let children actively participate in the HPV vaccination project.

Chengdu Daily Jinguan Journalist Wang Jingyu Source Health Chengdu Official WeChat Editor He Qixie Editor Liu Yonghao

- END -